Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations
Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 1904-1926
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 64
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
Svenja Müller, Laura Maintz, Thomas Bieber
Allergy (2024) Vol. 79, Iss. 6, pp. 1501-1515
Open Access | Times Cited: 45
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 447-461
Open Access | Times Cited: 29
Recent Advancements in the Atopic Dermatitis Mechanism
Maria Savva, Nikolaos G. Papadopoulos, Stamatios Gregoriou, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 17
Overview of Atopic Dermatitis in Different Ethnic Groups
Andrea Chiricozzi, Martina Maurelli, Laura Calabrese, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2701-2701
Open Access | Times Cited: 36
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Karolina Makowska, Joanna Nowaczyk, Leszek Blicharz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 781-781
Open Access | Times Cited: 35
Atopic dermatitis in children and adults
Andreas Wollenberg, Thomas Werfel, Johannes Ring, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 30
Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review
Anne‐Laure Demessant‐Flavigny, Sophie Connétable, Delphine Kérob, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. S5, pp. 3-17
Open Access | Times Cited: 29
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
Vanessa M. McDonald, Yuto Hamada, Álvar Agustí, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 824-837
Closed Access | Times Cited: 13
Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis
Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 11, pp. 2139-2148
Open Access | Times Cited: 9
Topical anti-inflammatory treatments for eczema: network meta-analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 8
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 2, pp. 651-660
Open Access | Times Cited: 20
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Lawrence F. Eichenfield, Richard Gower, Jinhua Xu, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 4, pp. 623-635
Open Access | Times Cited: 19
First update of the living European guideline (EuroGuiDerm) on atopic eczema
Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 11
Open Access | Times Cited: 19
The long‐term safety of topical corticosteroids in atopic dermatitis: A systematic review
Jane Harvey, S. Lax, A. Lowe, et al.
Skin Health and Disease (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 16
Should Emollients Be Recommended for the Prevention of Atopic Dermatitis?—New Evidence and Current State of Knowledge
Magdalena Grześk-Kaczyńska, Justyna Petrus-Halicka, Szymon Kaczyński, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 863-863
Open Access | Times Cited: 7
Dupilumab Treatment in Pediatric Patients Aged 6–11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review
Michael J. Cork, Simon G. Danby, Ana B. Rossi, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 277-289
Open Access | Times Cited: 6
Role of skin management in the prevention of atopic dermatitis and food allergy
Elizabeth Huiwen Tham, Kiwako Yamamoto‐Hanada, Agnes Sze Yin Leung, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 3
Closed Access | Times Cited: 6
Epicutaneous Sensitization and Food Allergy: Preventive Strategies Targeting Skin Barrier Repair—Facts and Challenges
Anna Dębińska, Barbara Sozańska
Nutrients (2023) Vol. 15, Iss. 5, pp. 1070-1070
Open Access | Times Cited: 14
Nanotechnology-Based Topical Delivery of Natural Products for the Management of Atopic Dermatitis
Mário Pedro Marques, Carla Varela, Laura Mendonça, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1724-1724
Open Access | Times Cited: 14
Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents
Carlo Caffarelli, Arianna Giannetti, Giuliana Giannì, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Atopic Dermatitis in the Elderly Population
Martina Maurelli, Andrea Chiricozzi, Ketty Peris, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv13363-adv13363
Open Access | Times Cited: 13
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration
Claudia Traidl‐Hoffmann, Jamie Afghani, Cezmi A. Akdiş, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2605-2624
Open Access | Times Cited: 5
Study on the clinical efficacy of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis in children
Yuping Zhang, Yueqing Chen, Li Chen
Medicine (2025) Vol. 104, Iss. 3, pp. e41277-e41277
Open Access
Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
Caleb W. Grote, Franziska Zirkenbach, Josef Wagner, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top